Grosen, A., Bungum, M.
, Hvas, C. L., Julsgaard, M., Cordelli, E.
& Kelsen, J. (2019).
Vedolizumab Does Not Impair Sperm DNA Integrity in Men With Inflammatory Bowel Disease.
Gastroenterology,
156(8), 2342-2344.
https://doi.org/10.1053/j.gastro.2019.02.041
Julsgaard, M., Kjeldsen, J.
, Bibby, B. M., Brock, B. & Baumgart, D. C. (2018).
Vedolizumab Concentrations in the Breast Milk of Nursing Mothers With Inflammatory Bowel Disease.
Gastroenterology,
154(3), 752-754.
https://doi.org/10.1053/j.gastro.2017.08.067
Julsgaard, M., Baumgart, D. C.
, Baunwall, S. M. D., Hansen, M. M., Grosen, A., Bibby, B. M., Uldbjerg, N., Kjeldsen, J., Sørensen, H. G., Larsen, L., Wildt, S., Weimers, P., Haderslev, K. V., Vind, I.
, Svenningsen, L., Brynskov, J.
, Lyhne, S., Vestergaard, T., Hvas, C. L. ... NOVA Study Group (2021).
Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study.
Alimentary Pharmacology and Therapeutics,
54(10), 1320-1329.
https://doi.org/10.1111/apt.16593
Attauabi, M., Höglund, C.
, Fassov, J., Pedersen, K. B., Hansen, H. B., Wildt, S., Jensen, M. D.
, Neumann, A., Lind, C., Jacobsen, H. A., Popa, A.-M., Kjeldsen, J., Pedersen, N., Molazahi, A., Haderslev, K., Aalykke, C., Knudsen, T., Cebula, W., Munkholm, P. ... Burisch, J. (2021).
Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases.
Scandinavian Journal of Gastroenterology,
56(9), 1040-1048.
https://doi.org/10.1080/00365521.2021.1946588
Tang, Y., Akbulut, H., Maynard, J.
, Petersen, L., Fang, X., Zhang, W.-W., Xia, X., Koziol, J., Linton, P.-J. & Deisseroth, A. (2006).
Vector prime/protein boost vaccine that overcomes defects acquired during aging and cancer.
Journal of Immunology,
177(8), 5697-707.
Han, T. H., Tang, Y., Park, Y. H., Maynard, J., Li, P., Akbulut, H.
, Petersen, L. & Deisseroth, A. (2010).
Vector prime protein boost vaccination in the setting of myeloablative-induced lymphopenia suppresses growth of leukemia and solid tumors.
Bone Marrow Transplantation,
45(3), 550-557.
https://doi.org/10.1038/bmt.2009.185
Rejnmark, L., Harsløf, T., Husted, L., Jensen, JEB.
, Mosekilde, L. & Langdahl, B. L. (2011).
VDR Polymorphism do not affect PTH response to vitamin D levels. Poster session præsenteret på 3rd joint meeting of the European Calcified Tissue Society and the International Bone and Mineral Society, Athens, Grækenland.
Lundgaard, A.
, Aalkjær, C., Bjurholm, A.
, Mulvany, M. J. & Hansen, E. S. (1997).
Vasorelaxation in isolated bone arteries. Vasoactive intestinal peptide, substance P, calcitonin gene-related peptide, and bradykinin studied in pigs.
Acta Orthopaedica (Print Edition),
68(5), 481-489.
Holmberg, M. J., Issa, M. S., Moskowitz, A., Morley, P., Welsford, M., Neumar, R., Paiva, E., Coker, A., Hansen, C. K.
, Andersen, L. W., Donnino, M. W., Berg, K. M. & Advanced Life Support Task Force at the International Liaison Committee on Resuscitation (ILCOR) (2019).
Vasopressors During Adult Cardiac Arrest: A Systematic Review and Meta-Analysis.
Resuscitation,
139(June), 106-121.
https://doi.org/10.1016/j.resuscitation.2019.04.008
Hoffert, J. D.
, Fenton, R., Møller, H., Simons, B., Tchapyjnikov, D., McDill, B. W., Yu, M.-J., Pisitkun, T., Chen, F. & Knepper, M. A. (2008).
Vasopressin-stimulated increase in phosphorylation at Ser269 potentiates plasma membrane retention of aquaporin-2.
Journal of Biological Chemistry,
283(36), 24617-27.
https://doi.org/10.1074/jbc.M803074200
Pedersen, N. B., Hofmeister, M. V., Rosenbaek, L. L., Nielsen, J. & Fenton, R. A. (2010).
Vasopressin induces phosphorylation of the thiazide-sensitive sodium chloride cotransporter in the distal convoluted tubule.
Kidney International,
78(2), 160-9.
https://doi.org/10.1038/ki.2010.130
Olesen, E. T. B., Rützler, M. R., Moeller, H. B., Praetorius, H. A. & Fenton, R. A. (2011).
Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus.
Proceedings of the National Academy of Sciences,
108(31), 12949-54.
https://doi.org/10.1073/pnas.1104691108
Tingskov, S. J., Choi, H.-J.
, Holst, M. R., Hu, S., Li, C., Wang, W.
, Frokiaer, J., Nejsum, L. N., Kwon, T.-H. & Norregaard, R. (2019).
Vasopressin-Independent Regulation of Aquaporin-2 by Tamoxifen in Kidney Collecting Ducts.
Frontiers in Physiology,
10(JUL), 1-13. Artikel 948.
https://doi.org/10.3389/fphys.2019.00948
Giesecke, T., Himmerkus, N.
, Leipziger, J., Bleich, M., Koshimizu, T. A., Fähling, M., Smorodchenko, A., Shpak, J., Knappe, C., Isermann, J.
, Ayasse, N., Kawahara, K., Schmoranzer, J., Gimber, N., Paliege, A., Bachmann, S. & Mutig, K. (2019).
Vasopressin Increases Urinary Acidification via V1a Receptors in Collecting Duct Intercalated Cells.
Journal of the American Society of Nephrology : JASN,
30(6), 946-961.
https://doi.org/10.1681/ASN.2018080816
Trimpert, C., van den Berg, D. T. M.
, Fenton, R. A., Klussmann, E. & Deen, P. M. T. (2012).
Vasopressin increases S261 phosphorylation in AQP2-P262L, a mutant in recessive nephrogenic diabetes insipidus.
Nephrology Dialysis Transplantation,
27(12), 4389-97.
https://doi.org/10.1093/ndt/gfs292
Hwang, S., Gunaratne, R., Rinschen, M. M., Yu, M.-J., Pisitkun, T., Hoffert, J. D.
, Fenton, R. A., Knepper, M. A. & Chou, C.-L. (2010).
Vasopressin increases phosphorylation of Ser84 and Ser486 in Slc14a2 collecting duct urea transporters.
American Journal of Physiology: Renal Physiology,
299(3), F559-67.
https://doi.org/10.1152/ajprenal.00617.2009
Andersen, L. W., Sindberg, B., Holmberg, M. J., Isbye, D. L., Kjaergaard, J., Zwisler, S. T., Darling, S., Larsen, J. M., Rasmussen, B. S.
, Løfgren, B., Glerup Lauridsen, K., Pælestik, K. B., Sølling, C., Kjærgaard, A. G., Due-Rasmussen, D., Folke, F., Charlot, M. G., Iversen, K., Schultz, M.
... Granfeldt, A. (2021).
Vasopressin and methylprednisolone for in-hospital cardiac arrest: Protocol for a randomized, double-blind, placebo-controlled trial.
Resuscitation Plus,
5, Artikel 100081.
https://doi.org/10.1016/j.resplu.2021.100081
Andersen, L. W., Holmberg, M. J., Høybye, M., Isbye, D., Kjærgaard, J., Darling, S., Zwisler, S. T., Larsen, J. M., Rasmussen, B. S., Iversen, K., Schultz, M.
, Sindberg, B., Fink Valentin, M. & Granfeldt, A. (2023).
Vasopressin and Methylprednisolone and Hemodynamics after In-Hospital Cardiac Arrest: A Post Hoc Analysis of the VAM-IHCA Trial.
Resuscitation,
191, Artikel 109922.
https://doi.org/10.1016/j.resuscitation.2023.109922
Bødtkjer, D. M. B., Matchkov, V., Bødtkjer, E., Nilsson, H. & Aalkjær, C. (2008).
Vasomotion has chloride-dependency in rat mesenteric small arteries.
Pflügers Archiv - European Journal of Physiology,
457(2), 389-404.
https://doi.org/10.1007/s00424-008-0532-3
Olsen, M. H., Wachtell, K.
, Aalkjær, C., Dige-Petersen, H., Rokkedal, J. & Ibsen, H. (2002).
Vasodilatory capacity and vascular structure in long-standing hypertension: a LIFE substudy.
American Journal of Hypertension,
15, 398-404.